Company: LGN
Filing Date: 2025-02-14
Form Type: DRS
Source: 0000950123-25-002471
Chunk: 94

Company: Legence Corp.
Filing Date: 2025-02-14
Form: DRS
Chunk 94
---
 million if the
underwriters exercise in full their option to purchase additional shares of Class A Common Stock) of net proceeds from the sale of the Class A Common Stock offered by us based upon the assumed public offering price of
$ per share of Class A Common Stock (the midpoint of the price range set forth on the cover page of this prospectus), after deducting underwriting discounts and commissions and estimated offering expenses payable by
us.

We intend to contribute all of the net proceeds from this offering (not including the exercise of the underwriters’ option to
purchase additional shares) to Legence Holdings in exchange for LGN Units. Legence Holdings intends to use such net proceeds from this offering for the repayment of outstanding borrowings under our Term Loan Credit Facility and for general corporate
purposes.

To the extent the underwriters’ option to purchase additional shares is exercised, we intend to use a portion of the net
proceeds received from the sale of additional shares to repurchase a portion of the shares of Class A Common Stock held by Legence Investment Aggregator II and the remaining portion of such net proceeds from the sale of additional shares will
be contributed to Legence Holdings in exchange for additional LGN Units, and Legence Holdings will use such net proceeds to purchase LGN Units, together with an equal number of shares of Class B Common Stock, from Legence Investment Aggregator
I (in each case, at a purchase price per LGN Unit and share of Class B Common Stock, or per share of Class A Common Stock, as applicable, equal to the public offering price per share of Class A Common Stock in this offering, net of
underwriting discounts and commissions). The proceeds will be used for such purposes in proportion to the Legence Investment Aggregators’ respective ownership interest in Legence.

As of December 31, 2024, we had an outstanding principal balance of approximately $ under the Term Loan
Credit Facility. The Term Loan Credit Facility matures on December 16, 2028. Legence Holdings can elect for borrowings of term loans (including delayed draw term loans) to be classified as either SOFR loans or base rate loans. SOFR loans bear
interest at a rate equal to SOFR plus a margin of either 2.75%, 3.00% or 3.25%, which margin is determined based on the Company’s most recently reported Consolidated First Lien Net Leverage Ratio (the “First Lien Net Leverage Ratio”),
generally defined as